Bayesian Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bayesian Capital Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-3,628	Closed	-$227K	–	759
2019 Q1	$227K	Sell	3,628 -11,696	-76%	-$803K	0.04%	448
2018 Q4	$915K	Buy	15,324 +4,764	+45%	+$286K	0.19%	173
2018 Q3	$681K	Buy	10,560 +5,076	+93%	+$283K	0.11%	258
2018 Q2	$247K	Buy	+5,484	New	+$219K	0.06%	462

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bayesian Capital Management's BEAT Position: Q2 2019 in Review

Bayesian Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 3,628 shares — an estimated $227K sold.

Bayesian Capital Management first reported a position in BEAT in Q2 2018 and held it in 4 quarters. The position peaked at $915K in Q4 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Bayesian Capital Management reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Bayesian Capital Management sold 3,628 BioTelemetry, Inc. shares in Q2 2019, an estimated $227K.
Bayesian Capital Management first reported a position in BioTelemetry, Inc. in Q2 2018 and held it in 4 quarters.
Bayesian Capital Management's BioTelemetry, Inc. position peaked at $915K in Q4 2018.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Bayesian Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.